LEADER 03864oam  2201153zu 450 
001 9910698112403321
005 20231121213355.0
035   $a(CKB)3450000000002082
035   $a(SSID)ssj0000620949
035   $a(PQKBManifestationID)11385775
035   $a(PQKBTitleCode)TC0000620949
035   $a(PQKBWorkID)10613580
035   $a(PQKB)22955192
035   $a(WaSeSS)Ind00030485
035   $a(OCoLC)62126885
035   $a(EXLCZ)993450000000002082
100   $a20160829d2005      uy 
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aDiagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose
210 31$a[Place of publication not identified]$cAgency for Healthcare Research and Quality$d2005
215   $a1 online resource
225 1 $aEvidence Reports/Technology Assessments ;$vno. 128
225 1 $aAHRQ publication ;$vno. 05-E026-2
300   $aBibliographic Level Mode of Issuance: Monograph
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vno. 128.
410  0$aAHRQ publication ;$vno. 05-E026-2.
606   $aRisk
606   $aCausality
606   $aDiabetes Mellitus
606   $aEvidence-Based Practice
606   $aClinical Medicine
606   $aProbability
606   $aGlucose Metabolism Disorders
606   $aMedicine
606   $aEpidemiologic Factors
606   $aEndocrine System Diseases
606   $aHealth Occupations
606   $aDisease
606   $aQuality of Health Care
606   $aStatistics as Topic
606   $aMetabolic Diseases
606   $aPublic Health
606   $aHealth Care Quality, Access, and Evaluation
606   $aHealth Care Evaluation Mechanisms
606   $aEnvironment and Public Health
606   $aNutritional and Metabolic Diseases
606   $aEpidemiologic Methods
606   $aDelivery of Health Care
606   $aInvestigative Techniques
606   $aDiagnostic Techniques and Procedures
606   $aEvidence-Based Medicine
606   $aRisk Factors
606   $aPrediabetic State
606   $aMedicine$2HILCC
606   $aHealth & Biological Sciences$2HILCC
606   $aClinical Endocrinology$2HILCC
615  2$aRisk.
615  2$aCausality.
615  2$aDiabetes Mellitus.
615  2$aEvidence-Based Practice.
615  2$aClinical Medicine.
615  2$aProbability.
615  2$aGlucose Metabolism Disorders.
615  2$aMedicine.
615  2$aEpidemiologic Factors.
615  2$aEndocrine System Diseases.
615  2$aHealth Occupations.
615  2$aDisease.
615  2$aQuality of Health Care.
615  2$aStatistics as Topic.
615  2$aMetabolic Diseases.
615  2$aPublic Health.
615  2$aHealth Care Quality, Access, and Evaluation.
615  2$aHealth Care Evaluation Mechanisms.
615  2$aEnvironment and Public Health.
615  2$aNutritional and Metabolic Diseases.
615  2$aEpidemiologic Methods.
615  2$aDelivery of Health Care.
615  2$aInvestigative Techniques.
615  2$aDiagnostic Techniques and Procedures.
615  2$aEvidence-Based Medicine.
615  2$aRisk Factors.
615  2$aPrediabetic State.
615  7$aMedicine
615  7$aHealth & Biological Sciences
615  7$aClinical Endocrinology
702   $aSantaguida$b Pasqualina
712 02$aUnited States Agency for Healthcare Research and Quality
712 02$aMcMaster University Evidence-based Practice Center,
801  0$bPQKB
906   $aBOOK
912   $a9910698112403321
996   $aDiagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose$93124443
997   $aUNINA